UNSPSC 51145202: Levofacetoperane or levophacetoperane

This classification denotes a cns stimulant with the molecular formula C15H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3SZ9ZII529, chemically known as 2-piperidinemethanol, alpha-phenyl-, acetate (ester), (r*,r*)-(-)- but more generally known as levofacetoperane, which bears US NIH Compound Identifier 65715. European Medicines Agency schedules Levofacetoperane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08469MIG.

UNSPSC 51145202 Levofacetoperane or levophacetoperane is a Commodity code that shows no relevant recent state and local procurement activity. The one recent opportunity tagged under this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023)—involves pharmaceutical products and medical equipment wholly unrelated to levofacetoperane as a chemical compound. The mismatch suggests either a data-entry error in the source database or an outdated code assignment within the state procurement system. State and local buyers do not appear to be actively soliciting levofacetoperane under this code designation in current markets.

No representative procurement activity supports a characterization of issuing-body mix, geographic concentration, or market demand under this Commodity code. Business development professionals should treat this code as inactive for state and local contracting purposes and investigate whether a different UNSPSC classification applies to their product or service offering.